25/11/2024

Kopran Ltd

BSE: 524280 NSE: KOPRAN

About the Company

Kopran Ltd. is a fully integrated pharmaceutical company that manufactures and supplies high-quality formulations and active pharmaceutical ingredients globally.
Pros
  • Company is almost debt free.
  • Company is expected to give good quarter
  • Company has been maintaining a healthy dividend payout of 70.4%
VS
Cons
  • Stock is trading at 3.86 times its book value
  • The company has delivered a poor sales growth of 11.4% over past five years.
  • Company has a low return on equity of 7.02% over last 3 years.
  • Earnings include an other income of Rs.17.4 Cr.
Stock PE: 41.6
ROCE: 11.4
Market Cap: 1610 Cr.
Book Value: 86.5
ROE: 8.53
Face Value: 10
Credit Report: View PDF

KOPRAN - Price Chart


Volume Chart

Last 30 Days Bulk Deals

SL# Symbol Name Date Client Buy/Sell Quantity Price Remark
1 KOPRAN Kopran Ltd. 23/12/2025 SILVERLEAF CAPITAL SERVICES PRIVATE LIMITED SELL 500,612 152 -
2 KOPRAN Kopran Ltd. 23/12/2025 NK SECURITIES RESEARCH PRIVATE LIMITED SELL 367,990 152 -
3 KOPRAN Kopran Ltd. 23/12/2025 NK SECURITIES RESEARCH PRIVATE LIMITED BUY 367,990 151 -
4 KOPRAN Kopran Ltd. 23/12/2025 SILVERLEAF CAPITAL SERVICES PRIVATE LIMITED BUY 500,612 152 -
SL# Symbol Name Date Client Buy/Sell Quantity Price Remark
Technical Indicators
Today's OPEN >= LOW and HIGH=CLOSE No
Is a 7 Days Breakout ? No
3 Days Consecutive Volume Spike: No
2 Days Consecutive Price Hike: Yes
Above 20 MA ? Below
Above 50 MA ? Below
Above 100 MA ? Below
Above 200 MA ? Below

Important Disclaimer

One Page Analysis is calculated on the basis of Technical factors. No News or Result-oriented factors were considered.

This is a free tool only to help traders on a technical basis.

* Consult your financial advisor before investing in a strong market as it is subject to high risk.